Research/art/teacher profile of a person
Name and surname:
doc. MUDr. Martin Čaprnda, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Čaprnda
I.2 - Name
Martin
I.3 - Degrees
doc. MUDr. PhD.
I.4 - Year of birth
1976
I.5 - Name of the workplace
1st Department of Internal Medicine, Comenius University in Bratislava, Faculty of Medicne and University Hospital Bratislava
I.6 - Address of the workplace
Dekanát LF UK, Špitálska ulica 24, 813 72 Bratislava
I.7 - Position
university teacher - associated professor
I.8 - E-mail address
martin.caprnda@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3106
I.10 - Name of the study field in which a person works at the university
Internal Medicine
I.11 - ORCID iD
0000-0002-5500-5525

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2001
II.c - Study field and programme
General Medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2001
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2006
II.c - Study field and programme
Internal Medicine
II.4 - Associate professor
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2021
II.c - Study field and programme
Internal Medicine
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Assistant Professor Comenius University in Bratislava, Faculty of Medicine 2005 - 2021
Associated Professor Comenius University in Bratislava, Faculty of Medicine 2021 - now
Physician University Hospital Bratislava, 2nd Department of Internal Medicine 2001 - 2016
Physician University Hospital Bratislava, 1st Department of Internal Medicine 2016 - now

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Specialization in Internal Medicine 1st Degree Slovak Medical University, Bratislava, Slovakia 2004
Specialization in Internal Medicine Institute for Postgradual Education in Medicine, Prague, Czech Republic 2010
Specialization in Healthcare Management Comenius University in Bratislava, Faculty of Medicine 2016

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Internal Propedeutics General Medicine I. + II. General Medicine
Internal Medicine General Medicine I. + II. General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
2
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
30
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
285
VI.1.b - Over the last six years
80
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
99
VI.1.b - Over the last six years
40
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
2984
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
2144
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
25
VI.1.b - Over the last six years
8
VI.2 - The most significant research/artistic/other outputs
1

Caprnda M, Zulli A, Shiwani HA, et al. The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure. Clin Exp Pharmacol Physiol. 2020 Jul;47(7):1120-1133. IF (JCR) 2020=2,557

2

Liskova A, Samec M, Koklesova L, Caprnda M, et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother. 2021 Jun;138:111430. IF (JCR) 2020=6,529

3

Abotaleb M, Kubatka P, Caprnda M, et al. Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomed Pharmacother. 2018 May;101:458-477. IF (JCR) 2018=3,743 

4

Lind M, Hayes A, Caprnda M, et al. Inducible nitric oxide synthase: Good or bad? Biomed Pharmacother. 2017 Sep;93:370-375. IF (JCR) 2017=3,457

5

Caprnda M, Kubatka P, Gazdikova K, et al. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders. Biomed Pharmacother. 2017 Jul;91:60-69. IF (JCR) 2017=3,457

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Kusenda P, Caprnda M, Gabrielova Z, Kukova N, Pavlovic S, Stefanickova J. Understanding Loss to Follow-Up in AMD Patients Receiving VEGF Inhibitor Therapy: Associated Factors and Underlying Reasons. Diagnostics (Basel). 2024;14(4):400. IF (JCR) 2022=3.6

2

Mihalov P, Hodosy J, Koščálová A, Čaprnda M, Kachlíková M, Jurenka J, Bendžala M, Sabaka P. Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit. Can J Infect Dis Med Microbiol. 2023 Sep 14;2023:4951273. IF (JCR) 2022=2.8

3

Russo E, Caprnda M, Kruzliak P, Conaldi PG, Borlongan CV, La Rocca G. Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications. Stem Cells Int. 2022 Jan 6;2022:2454168. IF (JCR) 2022=4.3

4

Jurenka J, Nagyová A, Dababseh M, Mihalov P, Stankovič I, Boža V, Kravec M, Palkovič M, Čaprnda M, Sabaka P. Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infect Dis Rep. 2022 Dec 11;14(6):1004-1016. IF (JCR) 2022=3.2

5

Mazurakova A, Koklesova L, Samec M, Kudela E, Sivakova J, Pribulova T, Pec MJ, Pec M, Kello M, Büsselberg D, Golubnitschaja O, Gaspar L, Caprnda M, Adamek M, Prosecky R, Eminova E, Baranenko D, Kruzliak P, Kubatka P, Biringer K. Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertens. 2022 Aug;29:72-85. IF (JCR) 2022=2.2

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Lind M, Hayes A, Caprnda M, et al. Inducible nitric oxide synthase: Good or bad? Biomed Pharmacother. 2017 Sep;93:370-375. CITATION: afonte RD, Wang L, Arbelaez CA, Dennison R, Teng YD. Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges. Adv Sci (Weinh). 2022 Mar 4:e2104136.  

2

Gasparova I, Kubatka P, Opatrilova R, Caprnda M, et al. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):1-14. CITATION: Rahm AK, Helmschrott M, Darche FF, et al. Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survival. ESC Heart Fail. 2021 Oct;8(5):3737-3747.

3

Abotaleb M, Kubatka P, Caprnda M, et al. Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomed Pharmacother. 2018 May;101:458-477. IF (JCR) 2018=3,743. CITATION: Plava J, Burikova M, Cihova M, et al. Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer. J Exp Clin Cancer Res. 2021 Sep 27;40(1):302.  

4

Liskova A, Samec M, Koklesova L, Caprnda M, et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother. 2021 Jun;138:111430. IF (JCR) 2020=6,529. CITATION: arghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog. 2021 Jun 22;17(6):e1009634.  

5

Gasparova I, Kubatka P, Opatrilova R, Caprnda M, et al. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):1-14. CITATION: Singh JA, Cleveland JD. Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data. Eur Heart J. 2019 Sep 21;40(36):3046-3054.  

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

2016-2019 Vedecká grantová agentúra Ministerstva školstva, vedy, výskumu a športu SR - VEGA 2/0161/16 - Vplyv chronického zápalu na kardiometabolické parametre

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Board Member of Slovak Society of Atherosclerosis Slovak Society of Atherosclerosis 2011 - now

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-27